Donepezil Hydrochloride Tablet, Film Coated
Product Images NDC 29300-248

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Donepezil Hydrochloride (NDC 29300-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 01

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 02

The text is describing an ADAS-cog change from baseline study, where the mean (+SE) change is given for Donepezil Hydrochloride 5mg and Placebo over 18 days. Clinical improvement is also mentioned.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 03

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 04

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 05

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 06

This is a chart showing the cumulative percentages of patients in different treatment groups based on their change in ADAS-cog scores, with the horizontal axis showing the change from baseline and the vertical axis showing the percentage of patients. The treatment groups include Donepezil Hydrochloride 10mg/day, Donepezil Hydrochloride 5mg/day, Galantamine, and Placebo. The chart also indicates the percentage of patients with 7-point and 4-point changes, as well as no change in ADAS-cog scores.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 07

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 08

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 09

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 10

This is a graph that shows the clinical improvement of 44 patients who were given Donepezil Hydrochloride 10mg/day for 6 months compared to a placebo group. The graph shows that the Donepezil group showed improvement while the placebo group declined.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 11

The text represents a graph showing the cumulative percentage of patients for Donepezil Hydrochloride and Placebo for a particular medication. The x-axis shows the ADCS-ADL change from the baseline, while the y-axis represents the cumulative percentage of patients. The graph shows that Donepezil Hydrochloride at 10mg/day is more effective than Placebo in improving cognitive function in patients.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 12

This is a table showing the change from baseline (in terms of LS mean) for two different drugs, Donepezil Hydrochloride 23mg/day and Donepezil Hydrochloride10mg/day, over the course of several weeks of drug treatment.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 13

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 14

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 15

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 16

Donepezil Hydrochloride Tablets, USP are available in a container of 30 tablets with each tablet containing 5mg of Donepezil Hydrochloride, USP. The recommended dosage should be as per the package insert. These tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and should be kept in a tight container. The product is manufactured by Unichem Laboratories Ltd, located in Pileme, Bardez, Goa, India and is exclusively manufactured for Unichem Pharmaceuticals (USA), Inc. in East Brunswick, NJ 08816. It is advised to keep these tablets, and all drugs, out of reach of children. NDC 29300-24813.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 17

This text contains information about a drug called Donepez Hydrochloride. The NDC number is 29300-249-13 and each tablet contains 10 mg of the drug. There is a dosage recommendation, which can be found in the accompanying package insert. The drug should be kept out of reach of children and stored in a controlled room temperature. The drug is manufactured by UNICHEM LABORATORIES LTD in Goa, India, and is distributed by UNICHEM PHARMACEUTICALS (USA), INC in New Jersey.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 18

Donepezil Hydrochloride Orally Disintegrating Tablets, USP are a prescription medication in the form of orally disintegrating tablets. One package contains 30 tablets with a total of 3x10 unit-dose blisters. The tablets are manufactured and distributed by UNICHEM LABORATORIES LTD. The label also contains the drug's NDC (National Drug Code) number, which is 29300-250-87. The manufacturer of the medication is UNICHEM PHARMACEUTICALS (USA), INC. The rest of the text is blurry and not legible.*

FDA Label Image

C40f39a9 434c 41f3 9258 Deb4a34457d3 19

Donepezil Hydrochloride in Orally Disintegrating Tablets is a medicine prescribed only with a Rx. It comes in a packaging of 30 tablets with 3 sets of 10-unit dose blisters. The package mentions UniChem Pharmaceuticals (USA), Inc. as manufacturers and gives their address in East Brunswick, NJ. The Orally Disintegrating Tablets are made by UniChem Laboratories Ltd. in India. The other text is not readable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.